Airway clearance is integral to the management of bronchiectasis, yet there is no evidence as to the optimal modality. The aim of this randomized prospective study was to evaluate the acute efficacy, acceptability and tolerability of three airway clearance techniques in non-cystic fibrosis (non-CF) bronchiectasis. Flutter, active cycle of breathing technique (ACBT) and ACBT with postural drainage (ACBT-PD) were evaluated in random order over a week in 36 patients (mean age 62 years, range 33-83), with stable non-CF bronchiectasis. Total sputum wet weight for ACBT-PD was twice that of either ACBT alone or Flutter. No objective difference in treatment duration was noted. All three techniques were well accepted and tolerated. Patient preference was 16 (44%) for Flutter, eight (22%) ACBT and 12 (33%) for ACBT-PD. Patient demography, factors such as upper airways or reflux symptoms, previous use or acute efficacy did not predict preference. This is the first randomized systematic evaluation of acute efficacy, acceptability and tolerability of Flutter, ACBT and ACBT-PD in non-CF bronchiectasis. All three techniques were well tolerated but ACBT-PD proved superior in terms of acute efficacy. Patient preference for treatment modality could not be predicted. Chronic Respiratory Disease 2007; 4: [23][24][25][26][27][28][29][30] Active Cycle of Breathing Technique (ACBT) 4,5
Background
Bronchiectasis is characterized by irreversibly dilated airways, generally associated with a vicious cycle of chronic inflammation and infection leading to chronic productive cough, accelerated decline in lung function and impaired health-related quality of life (HRQL). [1] [2] [3] Airway clearance techniques are regarded as an integral component of management. Active cycle of breathing technique (ACBT) is widely advocated 4 comprising breathing control, thoracic expansion exercises and forced expiratory technique which may be used with postural drainage (PD). 4, 5 Mechanical forms of airways clearance are also available: the Flutter (Scandipharm Inc., Birmingham, Alabama, USA) is a simple hand-held device that produces oscillating pressure on exhalation, which is postulated to loosen secretions, prevent airway closure and enhance clearance of secretions.
Previous studies have not demonstrated clear superiority of one technique. Valente et al. compared Flutter, positive expiratory pressure and control but this was a pilot study of only eight bronchiectasis patients. The primary outcome of sputum transport velocity was similar in all three groups. 6 Cecins et al. compared ACBT in the horizontal position versus ACBT with a head-down tilt in 19 bronchiectasis patients. No difference in acute sputum production was observed. 7 Patterson et al. reported a randomized crossover trial of ACBT versus Acapella (a handheld device which combines positive expiratory pressure with high-frequency oscillation therapy) in 20 bronchiectasis patients. 8 No significant differences were seen in acute sputum weight. However the ACBT arm included postural drainage with percussion and vibration which cannot be performed independently. Thompson et al. compared ACBT with Flutter in a randomized eight-week crossover study of 17 bronchiectasis patients. 9 No significant differences
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A randomized evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis were noted in median weekly sputum weight. However, the ACBT arm was not standardized with variable use of PD. There has been no direct comparison of the acute efficacy of Flutter with ACBT and ACBT-PD in non-CF bronchiectasis. The results of airway clearance literature in CF 10 are not necessarily directly extrapolatable given the fundamental differences in pathophysiology, sputum rheology, disease distribution and response to therapy between CF and non-CF bronchiectasis. 3 Contrary to CF, a large, six month, randomized, placebo-controlled trial in non-CF bronchiectasis found that the group receiving rhDNase had more exacerbations and greater fall in FEV 1 than the placebo group. 11 In addition to efficacy, the acceptability and tolerability of the clearance technique is an important consideration. PD may be less favoured due to a belief that it is less well tolerated especially in patients with rhinosinusitis and gastro-oesophageal reflux 7, 12 which are common in bronchiectasis. 2 Currie et al. reported a survey of PD in 50 chronic sputum producers: 31 noted two or more problems including discomfort and lack of time. 12 However, in this study PD was not standardized with a significant number of patients using percussion and so called 'shaking movements'. The incidence of adverse effects has never been systematically evaluated in bronchiectasis using carefully standardized techniques performed in accordance with current recommended practice. 4, 5 A number of authors have discussed how adherence may be significantly determined by the acceptability and tolerability of the clearance technique. 7, [12] [13] [14] Early acceptability and tolerability are likely influential in preference and ultimately adherence. If a technique is perceived to be unacceptable or poorly tolerated it is unlikely to be used sufficiently to assess long-term efficacy, acceptability or tolerability. There is a pressing need for long-term studies however long-term goals of airway clearance are unlikely to be realized if adherence is poor. A systematic evaluation such as this would be a valuable tool in the initial prescription of a clearance technique and would serve as a baseline measure for comparative purposes in the longer-term follow-up of airway clearance for bronchiectasis patients. Furthermore it would be a vital prerequisite for long-term clinical studies.
This prospective randomized controlled study aimed to compare the acute efficacy, acceptability and tolerability of Flutter with ACBT (with and without PD) in patients with non-CF bronchiectasis. A secondary aim was to evaluate preference and predictors of preference.
Methods

Patient selection
Consecutive patients with non-CF bronchiectasis referred to the Respiratory Physiotherapy Department at Green Lane Hospital were invited to participate. Inclusion criteria were non-CF bronchiectasis with chronic productive cough for which airway clearance had been advised by their usual healthcare provider. All patients had typical findings on high resolution computed tomography, clinical stability defined as no deterioration in respiratory symptoms requiring intervention with antibiotics or oral corticosteroids within the previous four weeks and age Ͼ17 years. Exclusion criteria were respiratory failure, inability to perform airway clearance techniques or inability to complete HRQL/Likert questionnaires.
Local Ethics Committee approval was obtained and all patients provided written informed consent.
Study design
Patients attended three visits over a seven day period (Day 1, 4, 7) standardized to the same time of day and with advice to withhold usual airway clearance 24 hours prior to attendance. At each session one of the following standardized airway clearance techniques (Flutter, ACBT, ACBT-PD) was performed in random order determined by computer-generated randomization with concealed allocation. Patients received comprehensive standardized practical and written instructions in each airway clearance technique. Patients were supervised throughout by an experienced senior respiratory physiotherapist (PY) to ensure each technique was performed in a standardized and optimal manner. The duration of treatment was recorded with the endpoint of each technique defined as two clear cycles and a dry sounding huff. 4 If this defined endpoint was not achieved within 30 minutes, the session was judged complete.
Introduction
Active cycle of breathing technique (ACBT) is used to mobilize and clear excess pulmonary secretions from the lung peripheries without increasing airflow obstruction. It is a combination of thoracic expansion exercises interspersed with breathing control followed by Forced Expiratory Technique (FET). FET is forced expiration with an open glottis combined with periods of breathing control.
Position
Sitting comfortably in a standard chair.
Stage 1 Chest expansions
1) Breathe gently at normal rate and depth using the lower chest (breathing control) 2) Breathe in slowly and deeply using the lower chest.
Pause 3) Breathe out fully but NOT FORCEFULLY 4) Repeat for a further two breaths 5) Return to breathing control 6) Take three further slow deep breaths as in steps 2-4 7) Return to breathing control
Stage 2 Sputum removal (Forced Expiratory Technique)
1) Take a slightly bigger than normal breath in 2) Open your mouth and keep it O shaped 3) Breathe out more forcefully using your abdominal muscles to assist. This should sound like a forced sigh.This is described as Huffing. Active cycle of breathing technique as described above in conjunction with postural drainage/gravity assisted drainage i.e, the use of specific positioning in which gravity enhances mucus transport from distal bronchi.
Position(s)
Lying comfortably in the appropriate gravity assisted drainage position. This will depend on the lung zones involved as identified on HRCT.
1) Perform ACBT as in previous instructions whilst in this position. 
Your positions are:
1) ---------------- 2) ----------------
Data collection
Demographic details and comorbidities potentially relevant to the performance of airway clearance techniques including gastroesophageal reflux, sinusitis, headache, chest wall discomfort or pelvic floor complaints were recorded. Disease-specific HRQL was evaluated with the St George's Respiratory Questionnaire (SGRQ). This instrument is reproducible and valid for bronchiectasis patients 15 is self-administered and comprises three domains; Symptoms, Activity and Impacts, each scored 0-100, (0 ϭ optimal).
Primary outcome measures
1) Acute efficacy -Sputum wet weight (g) is an accepted non-invasive measure of acute efficacy and is a good predictor of dry weight. 7 Sputum wet volumes (mL) were also recorded. Total weight/volume was defined as sputum collected during each airways clearance technique plus 30-minute post-treatment. 7 Patients were instructed not to swallow secretions and to avoid salivary contamination. 2) Physiological measures -Cutaneous pulse oximetry (Nellcor N-20PA Puritan Bennett Inc., Pleasanton CA, USA), spirometric lung volumes and the Borg dyspnoea score 16 were measured pre-and postairway clearance. Spirometry (R-Model Vitalograph Limited, Buckingham, England) was performed to Airway clearence techniques in bronchiectasis T Eaton et al.
ATS standards 17 and forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) expressed as % predicted using the European Community Coal and Steel prediction equations. 18 3) Acceptability and tolerability -During the 30-minute post-airway clearance period patients completed Likert scales assessing the following: usefulness, ease of understanding of instruction, ease of performance, degree of tiredness, discomfort, timeconsumption, interference with everyday life and embarrassment (1 ϭ extremely, 7 ϭ not at all).
Secondary outcome measures
1) Preference -At the final visit patients were asked their preferred clearance technique.
Data analyses
Allowing for a Type 1 error of 5%, a sample size of 36 will detect a 15% change in sputum weight 7 
Results
Thirty-seven patients were recruited; one withdrew due to an infective exacerbation of bronchiectasis. Baseline patient characteristics are detailed in Table 1 .
All patients had prior experience of airway clearance, with the majority 28 (78%), stating they had been prescribed ACBT-PD, the remainder eight (22%), ACBT.
No patient had been prescribed Flutter.
Acute efficacy of airway clearance techniques
Sputum weights and volumes are detailed in Table 2 . The mean difference in sputum weights and volumes was significantly greater for ACBT-PD. The differences between ACBT and Flutter were not significantly different.
Physiological measures
Borg dsypnoea scores were low and did not change significantly with any of the airway clearance techniques; nor was there change in oxygen saturation or FEV1.
Acute acceptability and tolerability of airway clearance techniques
ACBT-PD was perceived to be significantly more useful in clearing sputum than ACBT. All three airway clearance techniques were well accepted and tolerated as detailed in Table 3 . However, ACBT-PD was associated with significantly more discomfort and causing greater interference with daily life than ACBT and perceived as significantly more time-consuming than either ACBT or Flutter. Objective treatment duration was not significantly different ( Table 2) .
Preference
In response to specific enquiry, 16 (44%) indicated a preference for Flutter, eight (22%) for ACBT and 12 (33%) for ACBT-PD (P ϭ 0.26). Preference was not predicted by age (P ϭ 0.9), gender (P ϭ 0. were more likely to prefer Flutter. Patients who felt that ACBT interfered less with their daily life were more likely to choose ACBT than ACBT-PD, [odds ratio 6.1 (1.0, 35.8) (P ϭ 0.045)]. Prior use of ACBT or ACBT-PD did not predict patient preference (P ϭ 0.7). There was no evidence of a treatment order effect.
Discussion
Summary
This is the first study to systematically evaluate the acute acceptability and tolerability as well as acute efficacy of airway clearance techniques (Flutter and ACBT with and without PD) in non-CF bronchiectasis. Efficacy of ACBT with PD was superior to both ACBT alone and Flutter as measured by acute sputum production. All techniques were well tolerated acutely.
Acute efficacy of airway clearance techniques
Total sputum wet weight for ACBT-PD was twice that of either ACBT alone or Flutter with a mean difference of 5.6 g. Cecins et al. quoted 15% difference to be clinically significant 7 and more recently Patterson et al. quoted variously 3.5 g 19 and 3.8 g 8 as clinically important differences. We conclude our results to be clinically significant. The acute efficacy of ACBT with and without PD has not been previously been evaluated in non-CF bronchiectasis. Given that acute efficacy has been historically the main outcome measure in evaluating various airway clearance techniques, this is an important finding. Given that the only difference between ACBT and ACBT-PD was the postural drainage, it seems this is the defining component with respect to superior sputum clearance.
Acceptability, tolerability and perceived effectiveness of airway clearance techniques
Postural drainage has become less favoured due to a perception that is less well tolerated. However, we found that all three airway clearance techniques were well accepted and tolerated. ACBT-PD was perceived to be significantly more useful in clearing sputum than ACBT alone, supported by objective measures of sputum production. ACBT-PD was associated with statistically significantly more discomfort than ACBT (but not Flutter). ACBT-PD was perceived as significantly more time-consuming than either ACBT or Flutter, despite the fact that there were no significant differences in objective treatment duration. ACBT-PD also rated statistically significantly less well than Flutter in terms of interference with everyday life.
These were only statistically significant differences; the clinical significance of these small differences remains uncertain given that all techniques were generally well tolerated and these findings did not prove to have any bearing on final preference. Accordingly, there may be some perceptions/misperceptions with respect to ACBT-PD that need to be overcome.
Preferred airway clearance technique
There was no statistically significant difference in preference for any technique, however 16 (44%) indicated a preference for Flutter. An earlier study of Flutter 9 reported 11 out of 17 subjects preferred the Flutter to ACBT. Another study evaluating a similar device known as the Acapella 8 noted 14 out of 20 subjects preferred the Acapella. However the ACBT arm included vibration/percussion which might have influenced preference, given that this treatment cannot be performed independently. 'Medical devices' may have enhanced placebo effects compared with oral medications. 20 Preference for Flutter or Acapella may merely reflect the novelty of a new device. Furthermore, any initial enthusiasm may not translate to long-term adherence. While an older population might be expected to have less preference for devices, the mean age in our study was very comparable to previous studies of Flutter 9 and Acapella 8 and age was not a predictor for preference. The superiority of ACBT-PD in terms of acute efficacy did not predict preference. Neither did the presence of sinus or reflux symptoms, despite anecdotal reports that PD is poorly tolerated by such patients. However, ACBT-PD performed in 'optimal' standardized supervised conditions may be better tolerated and not directly comparable to the domiciliary setting. Neither objective nor subjective perception of treatment duration predicted preference. However, perception of usefulness and ease of performance of Flutter was predictive. Likewise a perception that ACBT interfered less with daily life predicted preference for ACBT over ACBT-PD.
Our study population, as indeed with the all previous studies of airway clearance in bronchiectasis, [7] [8] [9] was not naïve to airway clearance. The majority of our patients stated they had been prescribed ACBT-PD. No patient had been prescribed Flutter, a reflection of local practice, not dissimilar it seems to the UK. 21 However, prior experience of a particular airway clearance technique did not significantly influence preference. Overall, there was a lack of predictors of preference which is not surprising in that all three techniques rated well for acceptability and tolerablity.
Adherence
A prescription for airway clearance is not insignificant: it is generally a lifetime commitment with considerable potential barriers to adherence. Acceptability and tolerability of the proposed treatment is crucially relevant. Although, this is not a long-term study, we would contend that a lack of initial acceptability and tolerability is highly unlikely to be associated with longterm adherence. Given, longer-term adherence is crucial to realising long-term clinical benefit we would suggest that some trade-off on efficacy would be reasonable with patients able to make an informed choice.
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An informed choice will only be possible if there is a systematic approach to the prescription of airway clearance as outlined in this present study. We believe this approach could be usefully adapted as a routine model for clinical practice.
Strengths and weaknesses
Airway clearance techniques
We only employed clearance techniques able to be performed independently in the domiciliary setting. Each technique was very carefully standardized, a crucial but not invariable requirement. 22 However, the careful supervision by a senior experienced respiratory physiotherapist is not possible in the domiciliary setting with implications for patient education, quality assurance and maintenance of standards. We carefully defined end-of-treatment criteria a priori, thus heightening confidence in the accuracy and validity of our results.
Generalizability
Study patients comprised a wide spectrum of non-CF bronchiectasis: age range 33-83 years, FEV1%pred 24 -106 and mean HRQL as defined by SGRQ, uncannily comparable with another study of HRQL in bronchiectasis. 15 Patients were not naïve to airway clearance, in common with other studies. While this may have resulted in better acceptability and tolerability per se, we do not believe it would have significantly influenced the acute effects reported and does not negate our conclusions. Bronchiectasis is more prevalent in some ethnic groups including Maori and Pacific Islanders. 1 There may be important cultural differences in attitudes and beliefs but these could not be addressed in this study.
Outcome measures
We acknowledge the potential limitations of sputum volume as an outcome measure. In addition to day-to day and within-day variability, sputum volume is prone to inherent inaccuracies associated with underestimation (swallowing of secretions) and apparent over-production (saliva). We included sputum volumes (in addition to wet weights) since this is the measure that is employed in clinical practice, is directly visible to patients and thus potentially influences decisionmaking in regard to airway clearance.
Study design
Our study design allowed direct comparison between relevant subjective and objective measures. Acute efficacy measured objectively by sputum volume was very comparable with patient perception. Conversely, patients perceived ACBT-PD to be more time-consuming, whereas objective duration was not significantly different. We would argue that wherever possible it is preferable that perceptions/misperceptions be submitted to objective analysis, bringing patient and healthcare provider crucial objectivity required for a truly informed choice. Critical appraisal of acceptability and tolerability is a vital and ongoing component of airway clearance, with such an approach at least as important in airway clearance naïve patients.
Acute versus long-term
We accept that our study does not address longer-term outcomes and adherence however we would argue the approach, as outlined, is a vital prerequisite. However, acute acceptability and tolerability does not necessarily predict longer-term acceptability and tolerability and hence mandates regular review.
Tolerability
All three airway clearance techniques were well accepted and tolerated. The order of magnitude of the observed differences in acceptability and tolerability were small and although statistically significant, one should be cautious in interpretation with the clinical significance remaining uncertain. Similar caution should apply to interpretation of predictors of preference. However, this does not negate the merits of a systematic approach such as outlined to the prescription of airway clearance.
Conclusion
This is the first randomized systematic evaluation of acute efficacy, acceptability and tolerability of Flutter and ACBT with and without PD in non-CF bronchiectasis. First, while it is difficult to dismiss our findings of the very considerable superiority of ACBT-PD in terms of acute efficacy, how much weight should be placed on the acute efficacy of the technique per se is arguable, in that the longer term clinical significance of acute efficacy remains uncertain. Second, noting that postural drainage has become less favoured due to perceived tolerance issues, the importance of objective evaluation was highlighted in that all three modalities were well accepted and tolerated. Third, patient preference for a treatment modality could not generally be predicted.
